Comparative Pharmacology
Head-to-head clinical analysis: EPI E Z PEN JR versus WYAMINE SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: EPI E Z PEN JR versus WYAMINE SULFATE.
EPI E Z PEN JR vs WYAMINE SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Epinephrine is a direct-acting sympathomimetic amine that acts on alpha- and beta-adrenergic receptors. Alpha receptor activation increases peripheral vascular resistance and reverses hypotension, while beta receptor activation causes bronchodilation, increased heart rate, and myocardial contractility.
Wyamine sulfate (mephentermine sulfate) is a sympathomimetic amine that acts primarily by releasing norepinephrine from presynaptic nerve terminals, with direct alpha- and beta-adrenergic receptor agonist activity. It causes vasoconstriction and positive inotropic effects, increasing cardiac output and blood pressure.
Epinephrine 0.3 mg (0.3 mL of 1:1000 solution) intramuscularly into the anterolateral thigh, repeated every 5-15 minutes as necessary for anaphylaxis.
Intramuscular injection: 15-30 mg as a single dose; may repeat in 10-15 minutes if needed. Maximum total dose: 60 mg.
None Documented
None Documented
Short terminal half-life of approximately 2-3 minutes; requires continuous infusion for sustained effect due to rapid uptake and metabolism.
Terminal elimination half-life is 6-8 hours in adults with normal renal function (CrCl >90 mL/min).
Primarily renal: epinephrine is metabolized in the liver and tissues, with metabolites (metanephrine, vanillylmandelic acid) excreted in urine; <5% excreted unchanged.
Primarily renal; 90% excreted unchanged in urine within 24 hours. Minimal biliary/fecal elimination (<5%).
Category C
Category C
Sympathomimetic
Sympathomimetic